Skip to main content
JAZZ filings

Corporate insider profile

Mark Douglas Smith Filing Activity

Latest reported as Corporate insider of Jazz Pharmaceuticals plc (JAZZ).

Purchase filings
0
Reported companies
1
Net open-market value
-$266,746.35
Latest transaction
Jun 15, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 15, 2026Jazz Pharmaceuticals plc (JAZZ)Corporate insiderSale1,157$230.55$266,746